Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Vinculación Antes del Nacimiento: Una Intervención de Salud Móvil para Parejas Primerizas Embarazadas (B³)

3 de noviembre de 2026 actualizado por: Michelle Kee, Institute for Human Development and Potential (IHDP), Singapore

Vinculación Antes del Nacimiento: Un Ensayo Controlado, Aleatorizado por Grupos, de mHealth para Desarrollar la Atención Plena y la Regulación Emocional en Parejas Embarazadas

Emotional regulation is a key component of reducing parenting stress, a sense of self-efficacy, and thus successful parenting, child outcomes, and productivity amongst working parents. However, few interventions begin building these necessary components in pregnancy prior to the extremely stressful period immediately post-partum, where little trait and behavioural modification occurs. More importantly, most interventions overlook the importance of having both partners, despite fathers/partners playing a significant role in influencing maternal stress and mood symptoms.

This goal of this study is to examine whether short weekly exercises delivered through a mobile app can help first-time parents feel better emotionally during pregnancy. These exercises are designed to help people manage their emotions and stress. Researchers want to know if doing these exercises, along with getting weekly feedback and encouragement, can reduce signs of depression and improve emotional control.

Expecting mothers and fathers who are having their first child may be able to join the study if they meet certain conditions. Participants should be planning to stay in Singapore for the next two years and be comfortable using a smartphone and answering questions in English. Participants may benefit from learning new ways to manage stress and emotions, which could help improve their mental health.

Participants will wear a Fitbit watch to track activity. They will complete a short weekly survey about their well-being during pregnancy and a monthly survey about their work productivity until six months after the baby is born. They will also answer online surveys about their health, relationships, and background at the start, three times during pregnancy, and three times after birth. In addition, they will visit the research lab twice to take part in tasks that measure thinking and behaviour.

Descripción general del estudio

Descripción detallada

The overall goal of this study is to answer the following main questions:

  • Does the intervention improve parents' depressive symptoms scores, using the Edinburgh Postnatal Depression Scale as a proxy?
  • Does the intervention improve parents' emotional regulation skills?

The study involves 286 expectant couples (572 individuals) in a two-arm, cluster-randomized controlled trial with longitudinal observational follow-up until the child turns 6 months old. The active intervention comprises of customized, weekly recommendations of short (2-5 minute) audio clips featuring activities such as breathing exercises, meditation, mindful walking. These will be provided to adult participants (expectant couples). Couples enrolling in the study will randomly be allocated to either the control or intervention group by prespecified block sizes of 10. That is, a random number generator will be used to preset the assignments in groups of 10, such that every 10 consecutive enrolments will have exactly 5 controls and 5 interventions (1:1 allocation). While it is not possible to blind operational staff to assignments (different protocols to follow, highly unbalanced assignment), scheduling of enrolment visits will be done by different staff than those conducting the enrolment visits, and the assignment will only be made known to enrolment staff while conducting the visit itself and they will also not have access to the blocking and randomization algorithm.

Participants in the control, no-intervention group will have access to a mobile app with similar functions as the participants in the intervention group, except that no personalized modules are given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

Participants in the intervention group will have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Participants will also be re-randomized weekly to different modules within the app. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

The intervention will take place throughout pregnancy, beginning at enrollment ( when the mother is less than 20 gestational weeks of pregnancy), and continuing until the child is born. As gestational duration varies among participants, the total intervention period will range approximately from 17 to 28 weeks, depending on the timing of recruitment and delivery. All study arms will be assessed up to 6 months after birth.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

572

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Singapore, Singapur, 117609
        • Reclutamiento
        • Institute for Human Development and Potential (IHDP), Singapore
        • Contacto:
        • Investigador principal:
          • Michelle Z.L Kee, PhD
        • Investigador principal:
          • Cornelia Y.I Chee, MBBS, MMed
        • Investigador principal:
          • Bibhas Chakraborty, PhD
        • Sub-Investigador:
          • Xiaoxi Yan, PhD
        • Sub-Investigador:
          • Evelyn C Law, MD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

21 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Mothers:

  1. 21-50 years of age
  2. Less than 20 weeks of pregnancy, confirmed by ultrasonography upon enrolment
  3. Singleton pregnancy
  4. Nulliparous
  5. Plan to deliver in Singapore
  6. Proficient and able to respond to questionnaires in English
  7. Intends for herself and her child to stay in Singapore for the next 2 years
  8. Access to a smartphone
  9. Willing to download the study app
  10. Score of 7 or more in the Edinburgh Postnatal Depression Scale

Fathers:

  1. 21-75 years of age
  2. Proficient and able to respond to questionnaires in English
  3. Intends for himself and his child to stay in Singapore for the next 2 years
  4. Access to a smartphone
  5. Willing to download the study app

Exclusion Criteria:

Mothers:

  1. Any pre-existing or history of psychotic depression, schizophrenia, and bipolar disorders
  2. Currently on oral/IV steroids and/or thyroid medication
  3. History of thyroid disease
  4. Pregnant using assisted reproductive technologies
  5. Multiple pregnancies
  6. Currently enrolled in interventional randomised controlled trials
  7. Responded "Yes, quite often" to EPDS item 10 ("The thought of harming myself has occurred to me")

Fathers:

1. Currently enrolled in interventional randomised controlled trials

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Group A (Control)

Participants' will have access to a mobile app with similar functions as the participants in the intervention group, except that there are no personalized modules given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

Experimental: Group B (Intervention)

Participants have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

Participants in the intervention group will receive recommended modules in the mHealth app installed on their phones.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Parents' Depressive Symptoms
Periodo de tiempo: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment

Parents' level of depressive symptoms will be measured using the Edinburgh Postnatal Depression Scale.

Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Parents' emotional regulation skills
Periodo de tiempo: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months.

Examining self-reported parental emotional regulation skills using the Cognitive Emotion Regulation Questionnaire

Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Michelle Z.L Kee, PhD, Institute for Human Development and Potential

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

14 de julio de 2026

Finalización primaria (Estimado)

31 de diciembre de 2028

Finalización del estudio (Estimado)

31 de diciembre de 2028

Fechas de registro del estudio

Enviado por primera vez

16 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

16 de marzo de 2026

Publicado por primera vez (Actual)

19 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

3 de noviembre de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2026-049
  • H22P0M0001 (Otro número de subvención/financiamiento: A*STAR Human Health and Potential Prenatal/Early Childhood Grant)
  • H22P0M0009 (Otro número de subvención/financiamiento: A*STAR Human Health and Potential Prenatal/Early Childhood Grant)
  • NUHSRO/2025/082/NUSMed/024/B3 (Otro número de subvención/financiamiento: National University of Singapore)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

The decision regarding the availability of individual participant data for sharing requires further discussions between the institutes.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir